Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement. The protocol was prospectively registered with the International Prospective Register of Systematic Reviews (PROSPERO; registration number CRD420251115623).
Authors
- Xi Zhang (ORCID: https://orcid.org/0000-0002-4638-3997)
- Yue Li
- Yuying Gao
- Jun Zhang
- Hao Li
- Jie Chen
- Rui Li (ORCID: https://orcid.org/0009-0008-4964-2289)
- Siqiong Deng
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- First People's Hospital of Yunnan Province (CN)
- Second Hospital of Nanchang (CN)
- Rongcheng City People's Hospital (CN)
- Dali University (CN)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1007/s13300-025-01836-2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00